Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $320.00 price target on the stock.
Penumbra, Inc. (NYSE: PEN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors [Yahoo! Finance]